Benefit of Chemoradiotherapy Versus Chemotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer: The Randomized CONKO-007 Trial.

Journal:

Journal of Clinical Oncology

Published:

2025-08-14

DOI:

10.1200/jco-24-01502

Affiliations:

21

Authors:

23

Go to article

Institutions	Authors	Share
University of Erlangen-Nuremberg (FAU), Germany	3.333333	0.14
NCT WERA, Germany	2.833333	0.12
Comprehensive Cancer Center Erlangen-EMN (CCC), FAU, Germany	2.333333	0.10
Ruhr University Bochum (RUB), Germany	2.000000	0.09
St. Josef-Hospital, RUB, Germany	2.000000	0.09
non-affiliated author contributions, Germany	2.000000	0.09
University Medical Center Freiburg, Germany	1.000000	0.04
University Medical Center Göttingen (UMG), Germany	1.000000	0.04
University Hospital Magdeburg (UKMD), OVGU, Germany	1.000000	0.04
University Hospital of Cologne, Germany	1.000000	0.04
University Hospital Frankfurt, GU, Germany	1.000000	0.04
Saarland University Medical Center (UKS) / Faculty of Medicine, Saar-Uni, Germany	1.000000	0.04
Hospital Brothers of Mercy Regensburg, Germany	0.500000	0.02
University of Duisburg-Essen (UDE), Germany	0.500000	0.02
München Klinik Neuperlach, Germany	0.500000	0.02
University Hospital Aachen (UKA), RWTH Aachen, Germany	0.500000	0.02
Hospital Grosshadern, LMU, Germany	0.500000	0.02

Interested in Oncology and Carcinogenesis?